1. Hillemanns P, Wang X, Hertel H. Soergel P. Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2008, 198(3):300.e1-7. 2. Wang XL, Wang HW, Wang HS, et al. Topical 5- Aminolevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004, 151(4): 880-885. 3. 王秀丽, 王宏伟, 张玲琳, 等. 5-氨基酮戊酸光动力在尖锐湿疣诊断中应用. 中华皮肤科杂志. 2008, 41(5): 296-300. 4. Dougherty TY. Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol. 1987, 45: 879-889. 5. Munoz N, Bosch FX, de-Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348(6): 518-527. 6. Mathews WC. Screening for anal dysplasia associated with human papillomavirus. Top HIV Med. 2003, 11(2): 45-49. 7. Dalstein V, Rielhmuller D, Prtet JL, et a1.Persistent and load of high-risk HPV are predictors for development of high-grade cervical lesions:a longitudinal French cohort study. Int J Cancer. 2003, 106(3): 396-403. 8. 王秀丽, 王宏伟, 杨连娟, 等.上海地区女性外阴尖锐湿疣患者宫颈HPV感染及分型研究. 中华皮肤科杂志. 2009, 42(11):739-41. 9. Wang XL, Wang HW, Huang Z, et al. Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of ALA in urethral condylomata acuminate. Photochem and Photobiol. 2007, 83(5):1069-1073. |